Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
about
DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinomaNitric oxide synthase derangements and hypertension in kidney diseaseA functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivityDimethylarginine dimethylaminohydrolase 2, a newly identified mitochondrial protein modulating nitric oxide synthesis in normal human chondrocytes.Pilot study of the association of the DDAH2 -449G polymorphism with asymmetric dimethylarginine and hemodynamic shock in pediatric sepsis.The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.Effect of DDAH/ADMA/NOS regulation pathway on cavernae corporum cavernosorum rat penis of different age.Involvement of DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP Pathways in Human Tissue Kallikrein 1 Protecting Erectile Function in Aged RatsCommon genetic variants in the endothelial system predict blood pressure response to sodium intake: the GenSalt study.Centenarians as super-controls to assess the biological relevance of genetic risk factors for common age-related diseases: a proof of principle on type 2 diabetes.Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study.Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia.A genome-wide association study of the human metabolome in a community-based cohortEndogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?Nitric oxide (NO) and asymmetric dimethylarginine (ADMA): their pathophysiological role and involvement in intracerebral hemorrhage.Nitric oxide in the normal kidney and in patients with diabetic nephropathy.Genotype/allelic combinations as potential predictors of myocardial infarction.Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.Reply: To PMID 24259407Identification of a high-affinity network of secretagogin-binding proteins involved in vesicle secretion
P2860
Q24606042-64EAD19F-6090-4888-9172-0AD27160CC46Q26849234-4400D84C-A73E-4886-B81D-FE5EFEC1B387Q28730293-BB9087D2-B858-442F-B6E1-5E3E5924459FQ34013046-2001FFCD-AF27-42B0-B040-BCEC18F758F7Q34200808-D8BE647D-3126-41C1-873C-F32B77754CEEQ34632841-EC199869-84BE-4E88-B2CB-6BB0698F5506Q35641983-8228D510-747A-4E34-885B-83D85FCEF9FFQ36253972-999B916A-5216-418F-88AC-65BBCA5E81ADQ36853850-F9AF3B17-D9FE-4AB0-96FF-469F2E642700Q36981498-A1357963-BB2B-43CF-BA77-84C4871F6765Q37290635-E036292E-3D78-48CE-8EA3-DA2AC85B2A63Q37336634-270F865A-4FBD-4AC7-8778-2405B6AFFAF9Q37540307-9897F431-2645-477E-88B6-599532675D02Q37680072-3D0AC8F6-655D-4C63-BACF-98E76852F44BQ37684919-D4073B24-6968-4A72-8B39-314AAFC0910AQ37888834-95B13B46-3ADC-4F93-84D8-64978A1A2054Q38248725-9437CC74-2756-4524-8940-8A1F92308100Q41054425-5E677492-3088-4102-90AB-7355B9AFFFCEQ41870668-AF5A5673-52C9-4463-8306-83A2891C3309Q47919582-7E392F91-1600-406E-BC5B-7E3D46E4C2F5Q56931587-9B384F5B-47A8-42D6-8E0F-954A3765B698Q57904140-DB3704A5-693F-475B-9BE3-3C539BAFECA5
P2860
Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Sequence variation in DDAH1 an ...... ividuals with type 2 diabetes.
@ast
Sequence variation in DDAH1 an ...... ividuals with type 2 diabetes.
@en
Sequence variation in DDAH1 an ...... ividuals with type 2 diabetes.
@nl
type
label
Sequence variation in DDAH1 an ...... ividuals with type 2 diabetes.
@ast
Sequence variation in DDAH1 an ...... ividuals with type 2 diabetes.
@en
Sequence variation in DDAH1 an ...... ividuals with type 2 diabetes.
@nl
prefLabel
Sequence variation in DDAH1 an ...... ividuals with type 2 diabetes.
@ast
Sequence variation in DDAH1 an ...... ividuals with type 2 diabetes.
@en
Sequence variation in DDAH1 an ...... ividuals with type 2 diabetes.
@nl
P2093
P2860
P1433
P1476
Sequence variation in DDAH1 an ...... ividuals with type 2 diabetes.
@en
P2093
Abraham Kuot
Jamie E Craig
Malcolm J Whiting
Nicholas Kasmeridis
Shahrbanou Javadiyan
Sotoodeh Abhary
P2860
P356
10.1371/JOURNAL.PONE.0009462
P407
P577
2010-03-01T00:00:00Z